News

Balancing Stroke and Bleeding Risks in Patients With Atrial Fibrillation and Renal Failure: the Swedish Atrial Fibrillation Cohort Study

25.04.20141889

The data in this retrospective study of 283,969 patients with AF were obtained by analysis of health care databases in Sweden.

Peritoneal ultrafiltration in end-stage congestive heart failure

24.04.20141657

Congestive heart failure (CHF) refractory to pharmacological therapy is a growing medical problem.

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial

23.04.20141878

Serelaxin is effective in relieving dyspnoea and improving multiple outcomes in acute heart failure (AHF).

Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy

22.04.20141647

Cardiac resynchronization therapy (CRT) is associated with improved morbidity and mortality in patients with chronic heart failure (CHF) on optimal medical therapy.

A prospective study about impact of renal dysfunction and morbidity and mortality on cardiovascular events after ischemic stroke

21.04.20141870

The aim of our prospective study was to define the impact of renal dysfunction on future cardiovascular events and total mortality in 390 patients suffering from ischemic stroke.

Current Evidence on Treatment of Patients With Chronic Systolic Heart Failure and Renal Insufficiency: Practical Considerations From Published Data

18.04.20142686

What is the current evidence regarding the interactions between heart failure (HF) and renal dysfunction, and what is the effect of key disease-modifying therapies used in HF in patients with renal dysfunction?

EMA: Don't Combine ARBs, ACE Inhibitors, and Direct Renin Inhibitors

17.04.20142333

No two drug classes that act separately on the renin-angiotensin system (RAS) should be used in combination, the European Medicines Agency (EMA) warned today.